Nebius Shares Drop on $4.5 Billion Convertible Notes Offering and Exchange Deals
Shares fall in premarket on dilution fears as funds target AI data centers and GPUs.
NOTRELOAD AI
Merck and Moderna’s Personalized mRNA Vaccine Succeeds in First Phase 3 Melanoma Trial
Merck and Moderna’s personalized mRNA vaccine with Keytruda reduced melanoma recurrence in a 1,137-patient Phase 3 trial—the first late-stage win for an mRNA cancer vaccine.
Target’s Solid Q2 Masked by One-Time Tariff Refunds as Shares Slip
Target posts strong Q2 results and lifts full-year guidance on turnaround progress, yet mixed investor reaction reflects uneven categories and one-time tariff boosts.
Lowe’s Cuts Full-Year Forecast After Soft Second Quarter; Pro and Online Sales Provide Lift
Lowe’s says business is on a “good trajectory” into Q3 with expected strength & momentum in its Total Home strategy in 2H26, while focusing on market share gains and cost discipline.
Estée Lauder Beats Expectations as Strong China Demand Fuels Fiscal 2026 Growth
Estée Lauder posts stronger fiscal 2026 results with 5% sales growth and higher margins, driven by China demand. Raises 2027 profit outlook above consensus.
SK Hynix to Cancel $29 Billion Worth of Shares — Biggest Move in South Korea History
SK Hynix expands returns beyond 50% of FCF with buybacks, dividends and possible special payouts.